AGEs (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "AGEs" in Japanese language version.

refsWebsite

Global rank Japanese rank

64nih.gov

4^th place

24^th place

45doi.org

2^nd place

6^th place

3jbc.org

4,455^th place

3,334^th place

2sciencedirect.com

149^th place

558^th place

2biochemj.org

low place

2nature.com

234^th place

363^rd place

1ahajournals.org

3,608^th place

7,627^th place

1karger.com

4,489^th place

low place

1web.archive.org

1^st place

1hindawi.com

6,828^th place

6,917^th place

1arkray.co.jp

low place

1icmr.nic.in

low place

1archive.is

87^th place

39^th place

1mendeley.com

low place

1ds-pharma.jp

low place

1jsps.go.jp

low place

2,025^th place

1age-sokutei.jp

low place

age-sokutei.jp

“AGEs（終末糖化物質）を測るには”. AGE測定推進協会. 2015年2月22日閲覧。

ahajournals.org

circ.ahajournals.org

Goldin A, Beckman JA, Schmidt AM, Creager MA (2006-08-08). “Advanced glycation end products: sparking the development of diabetic vascular injury.”. Circulation 114 (6): 597-605. doi:10.1161/CIRCULATIONAHA.106.621854. PMID 16894049.

archive.is

A. Gugliucci. “Sour Side of Sugar, A Glycation Web Page”. 2015年9月21日閲覧。

arkray.co.jp

ebn.arkray.co.jp

“糖化ストレスとAGEs受容体”. からだサポート研究所. 2015年9月21日閲覧。

biochemj.org

Iijima K, Murata M, Takahara H, et al (2000-04-01). “Identification of N^ω-carboxymethylarginine as a novel acid-labile advanced glycation end product in collagen.”. Biochem J. 347 (Pt.1): 23-7. doi:10.1042/bj3470023. PMID 10727397.
Smedsrød B, Melkko J, Araki N, Sano H, Horiuchi S (1997). “Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells”. Biochem. J. 322 (Pt 2): 567–73. PMC 1218227. PMID 9065778.

doi.org

Goldin A, Beckman JA, Schmidt AM, Creager MA (2006-08-08). “Advanced glycation end products: sparking the development of diabetic vascular injury.”. Circulation 114 (6): 597-605. doi:10.1161/CIRCULATIONAHA.106.621854. PMID 16894049.
Vistoli, G; De Maddis, D; Cipak, A; Zarkovic, N; Carini, M; Aldini, G (Aug 2013). “Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.”. Free Radic Res. 47 (12): Suppl 1:3–27. doi:10.3109/10715762.2013.815348. PMID 10946212.
Nagai R, Ikeda K, Higashi T, et al (1997-05-08). “Hydroxyl radical mediates N^ε-(carboxymethyl)lysine formation from Amadori product.”. Biochem Biophys Res Commun 234 (1): 167-72. doi:10.1006/bbrc.1997.6608. PMID 9168983.
Nagai R, Fujiwara Y, Mera K, et al (2008-03-20). “Immunochemical detection of N^ε-(carboxyethyl)lysine using a specific antibody.”. J Immunol Methods. 332 (1-2): 112-20. doi:10.1016/j.jim.2007.12.020. PMID 18242632.
Iijima K, Murata M, Takahara H, et al (2000-04-01). “Identification of N^ω-carboxymethylarginine as a novel acid-labile advanced glycation end product in collagen.”. Biochem J. 347 (Pt.1): 23-7. doi:10.1042/bj3470023. PMID 10727397.
Miyata, T; Oda, O; Inagi, R; Iida, Y; Araki, N; Yamada, N; Horiuchi, S; Taniguchi, N et al. (September 1993). “beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.”. The Journal of Clinical Investigation 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584.
Uribarri, J; Woodruff, S; Goodman, S; Cai, W; Chen, X; Pyzik, R; Yong, A; Striker, GE et al. (June 2010). “Advanced glycation end products in foods and a practical guide to their reduction in the diet”. Journal of the American Dietetic Association 110 (6): 911–16.e12. doi:10.1016/j.jada.2010.03.018. PMC 3704564. PMID 20497781.
Koschinsky, T; He, CJ; Mitsuhashi, T; Bucala, R; Liu, C; Buenting, C; Heitmann, K; Vlassara, H (Jun 10, 1997). “Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.”. Proceedings of the National Academy of Sciences of the United States of America 94 (12): 6474–9. doi:10.1073/pnas.94.12.6474. PMC 21074. PMID 9177242.
Goldin A, Beckman JA, Schmidt AM, Creager MA (2006). “Advanced glycation end products: sparking the development of diabetic vascular injury”. Circulation 114 (6): 597–605. doi:10.1161/CIRCULATIONAHA.106.621854. PMID 16894049.
Song X, Bao M, Li D, Li YM (1999). “Advanced glycation in D-galactose induced mouse aging model”. Mech Ageing Dev 108 (3): 239–51. doi:10.1016/S0047-6374(99)00022-6. PMID 10405984.
Gugliucci A, Kotani K, Taing J, et al. (2009-08). “Short-Term Low Calorie Diet Intervention Reduces Serum Advanced Glycation End Products in Healthy Overweight or Obese Adults.”. Ann Nutr Metab. 54 (3): 197-201. doi:10.1159/000217817. PMID 19420913.
Brownlee, M (June 2005). “The pathobiology of diabetic complications: a unifying mechanism.”. Diabetes 54 (6): 1615–25. doi:10.2337/diabetes.54.6.1615. PMID 15919781.
Dominiczak MH (2003). “Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine”. Clin. Chem. Lab. Med. 41 (9): 1266–78. doi:10.1515/CCLM.2003.194. PMID 14598880.
Vlassara H, Palace MR.; Palace (2002). “Diabetes and advanced glycation endproducts”. J Intern Med. 251 (2): 87–101. doi:10.1046/j.1365-2796.2002.00932.x. PMID 11905595.
Glenn, J.; Stitt, A. (2009). “The role of advanced glycation end products in retinal ageing and disease”. Biochimica et Biophysica Acta 1790 (10): 1109–1116. doi:10.1016/j.bbagen.2009.04.016. PMID 19409449.
Semba, R. D.; Ferrucci, L.; Sun, K.; Beck, J.; Dalal, M.; Varadhan, R.; Walston, J.; Guralnik, J. M. et al. (2009). “Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women”. Aging clinical and experimental research 21 (2): 182–190. doi:10.1007/BF03325227. PMC 2684987. PMID 19448391.
Semba, R.; Najjar, S.; Sun, K.; Lakatta, E.; Ferrucci, L. (2009). “Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults”. American journal of hypertension 22 (1): 74–79. doi:10.1038/ajh.2008.320. PMC 2637811. PMID 19023277.
Yan, S. F.; D'Agati, V.; Schmidt, A. M.; Ramasamy, R. (2007). “Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging”. Current molecular medicine 7 (8): 699–710. doi:10.2174/156652407783220732. PMID 18331228.
Pertyńska-Marczewska, M; Głowacka, E; Sobczak, M; Cypryk, K; Wilczyński, J (February 2009). “Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies.”. American journal of reproductive immunology (New York, N.Y. : 1989) 61 (2): 175–82. doi:10.1111/j.1600-0897.2008.00679.x. PMID 19143681.
Srikanth, V; Maczurek, A; Phan, T; Steele, M; Westcott, B; Juskiw, D; Münch, G (May 2011). “Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.”. Neurobiology of Aging 32 (5): 763–77. doi:10.1016/j.neurobiolaging.2009.04.016. PMID 19464758.
Simm, A; Wagner, J; Gursinsky, T; Nass, N; Friedrich, I; Schinzel, R; Czeslik, E; Silber, RE et al. (July 2007). “Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery?”. Experimental Gerontology 42 (7): 668–75. doi:10.1016/j.exger.2007.03.006. PMID 17482402.
Shaikh S, Nicholson LF (2008-07). “Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation.”. J Neurosci Res. 86 (9): 2071-82. doi:10.1002/jnr.21644. PMID 18335520.
Fuentealba D, Friguet B, Silva E (2009). “Advanced glycation endproducts induce photocrosslinking and oxidation of bovine lens proteins through type-I mechanism.”. Photochem Photobiol. 85 (1): 185-94. doi:10.1111/j.1751-1097.2008.00415.x. PMID 18673320.
Gul A, Rahman MA, Hasnain SN (2009-06). “Role of fructose concentration on cataractogenesis in senile diabetic and non-diabetic patients.”. Graefes Arch Clin Exp Ophthalmol. 247 (6): 809-14. doi:10.1007/s00417-008-1027-9. PMID 19198870.
Haus, JM; Carrithers, JA; Trappe, SW; Trappe, TA (December 2007). “Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle.”. Journal of applied physiology (Bethesda, Md. : 1985) 103 (6): 2068–76. doi:10.1152/japplphysiol.00670.2007. PMID 17901242.
Gugliucci A, Bendayan M (1996). “Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE peptides by renal proximal tubular cells”. Diabetologia 39 (2): 149–60. doi:10.1007/BF00403957. PMID 8635666.
Ansari NA1, Moinuddin, Ali R (2011). “Glycated lysine residues: a marker for non-enzymatic protein glycation in age-related diseases”. DISEASE MARKERS 30 (6): 317-324. doi:10.3233/DMA-2011-0791. PMC 3825483. PMID 21725160.
Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW (1995). “Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose”. Biochemistry 34 (11): 3702–9. doi:10.1021/bi00011a027. PMID 7893666.
Gugliucci A, Mehlhaff K, Kinugasa E (2007). “Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance”. Clin. Chim. Acta 377 (1–2): 213–20. doi:10.1016/j.cca.2006.09.028. PMID 17118352.
Svistounov D, Smedsrød B (2004). “Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?”. J. Hepatol. 41 (6): 1038–40. doi:10.1016/j.jhep.2004.10.004. PMID 15582139.
Hira Zafar, (26 June 2012). “Inhibition of protein glycation and advanced glycation end products by ascorbic acid”. African Journal of Biotechnology 11 (51). doi:10.5897/AJB11.4172.
Abdul, HM; Butterfield, DA (Feb 1, 2007). “Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.”. Free radical biology & medicine 42 (3): 371–84. doi:10.1016/j.freeradbiomed.2006.11.006. PMC 1808543. PMID 17210450.
“Aspirin inhibits the formation of... preview & related info”. Mendeley. doi:10.1016/j.diabres.2006.12.024. 2013年11月13日閲覧。
Bucala R, Cerami A (1992). “Advanced glycosylation: chemistry, biology, and implications for diabetes and aging”. Adv. Pharmacol.. Advances in Pharmacology 23: 1–34. doi:10.1016/S1054-3589(08)60961-8. ISBN 9780120329236. PMID 1540533.
Guiotto A, Calderan A, Ruzza P, Borin G (2005). “Carnosine and carnosine-related antioxidants: a review”. Current Medicinal Chemistry 12 (20): 2293–2315. doi:10.2174/0929867054864796. PMID 16181134.
“Novel inhibitors of advanced glycation endproducts”. Arch. Biochem. Biophys. 419 (1): 63–79. (2013-03-25). doi:10.1016/j.abb.2003.08.009. PMID 14568010.
Mizutani, K; Ikeda, K; Yamori, Y (Jul 21, 2000). “Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.”. Biochemical and Biophysical Research Communications 274 (1): 61–7. doi:10.1006/bbrc.2000.3097. PMID 10903896.
Tang Y (May 2014). “Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling.”. Lab Invest. 94 (5): 503-16. doi:10.1038/labinvest.2014.42. PMID 24614199.
Ryoji Nagai, Jun-ichi Shirakawa, Rei-ichi Ohno, Narumi Moroishi, M. Nagai (2013). “Inhibition of AGEs formation by natural products”. Amino acids 46 (2). doi:10.1007/s00726-013-1487-z.
“N-Acetyl Cysteine Attenuated the Deleterious Effects of Advanced Glycation End-Products on the Kidney of Non-Diabetic Rats”. Cellular Physiology and Biochemistry 40 (3-4). (2016). doi:10.1159/000452574.
Upadhyay A, Tuenter E, Ahmad R, et al. (2014-08). “Kavalactones, a novel class of protein glycation and lipid peroxidation inhibitors.”. Planta Med. 80 (12): 1001-8. doi:10.1055/s-0034-1382949. PMID 25098935.
Vasan, S; Zhang, X; Zhang, X; Kapurniotu, A; Bernhagen, J; Teichberg, S; Basgen, J; Wagle, D; Shih, D; Terlecky, I; Bucala, R; Cerami, A; Egan, J; Ulrich, P (Jul 18, 1996). “An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.”. Nature 382 (6588): 275–8. doi:10.1038/382275a0. PMID 8717046.
Monnier, V. M., Mustata, G. T., Biemel, K. L., Reihl, O., Lederer, M. O., Zhenyu, D. (2005). “Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: An update on "a puzzle nearing resolution"”. Annals of the New York Academy of Sciences 1043: 533–544. doi:10.1196/annals.1333.061. PMID 16037276.
Furber, J.D. (2006). “Extracellular glycation crosslinks: Prospects for removal”. Rejuvenation Research (Elsevier Inc.) 9 (2): 274–278. doi:10.1089/rej.2006.9.274. PMID 16706655.
Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S (2012-11). “Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.”. Horm Metab Res. 44 (12): 891-5. doi:10.1055/s-0032-1321878. PMID 22864903.